Tongli Pharmaceuticals (USA), Inc. (TGLP) financial statements (2021 and earlier)

Company profile

Business Address 125 MAIDEN LANE, SUITE 309
NEW YORK, NY 10038
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments81
Cash and cash equivalents81
Receivables2,966
Inventory, net of allowances, customer advances and progress billings389
Inventory389
Advances on inventory purchases44
Prepaid expense and other current assets11
Other undisclosed current assets579
Total current assets:4,070
Noncurrent Assets
Property, plant and equipment5,953
Intangible assets, net (including goodwill)3,277
Intangible assets, net (excluding goodwill)3,277
Deposits noncurrent assets8,761
Total noncurrent assets:17,990
TOTAL ASSETS:22,060
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,332
Accounts payable355
Accrued liabilities212
Taxes payable765
Due to related parties261
Total current liabilities:1,593
Noncurrent Liabilities
Total liabilities:1,593
Stockholders' equity
Stockholders' equity attributable to parent20,467
Common stock15
Additional paid in capital9,094
Accumulated other comprehensive income2,456
Retained earnings8,902
Total stockholders' equity:20,467
TOTAL LIABILITIES AND EQUITY:22,060

Income statement (P&L) ($ in thousands)

3/31/2013
Revenues
(Revenue, Net)
11,106
Cost of revenue
(Cost of Goods and Services Sold)
(5,505)
Other undisclosed gross profit9
Gross profit:5,610
Operating expenses(3,370)
Operating income:2,239
Nonoperating expense(82)
Investment income, nonoperating40
Other nonoperating income40
Interest and debt expense(37)
Other undisclosed income from continuing operations before equity method investments, income taxes37
Income from continuing operations before income taxes:2,158
Income tax expense(664)
Net income available to common stockholders, diluted:1,493

Comprehensive Income ($ in thousands)

3/31/2013
Net income:1,493
Comprehensive income:1,493
Other undisclosed comprehensive income, net of tax, attributable to parent380
Comprehensive income, net of tax, attributable to parent:1,874

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: